Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Hertler

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cancer Treatment and Research|January 1, 1988
Human immune response to immunotoxinsA A Hertler
Cancer Investigation|January 1, 1991
Immunotoxins in the therapy of leukemias and lymphomasA A Hertler, A E Frankel
Clinics in Geriatric Medicine|November 1, 1987
Sarcomas in the elderlyA A Hertler, J O Moore
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Immunotoxins: a clinical review of their use in the treatment of malignanciesA A Hertler, A E Frankel
Journal of Clinical & Laboratory Immunology|December 1, 1986
Effect of intravenous immunoglobulin on E. coli opsonization in multiple myelomaA A Hertler, S C Ross
American Journal of Hematology|December 1, 1986
Isolated anterior chamber relapse in acute monoblastic leukemiaA A Hertler, G O Rosenwasser, W L Gluck
Cancer Drug Delivery|January 1, 1987
Humoral immune response to a ricin A chain immunotoxin in patients with metastatic melanomaA A Hertler, L E Spitler, A E Frankel
Cancer Immunology, Immunotherapy : CII|January 1, 1989
An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeysA A Hertler, D M Schlossman, M J Borowitz, et al.
Cancer Treatment and Research|January 1, 1988
Treatment of leukemia patients with T101 ricin A chain immunotoxinsG Laurent, A E Frankel, A A Hertler, et al.
International Journal of Cancer|February 15, 1989
An anti-CD5 immunotoxin for chronic lymphocytic leukemia: enhancement of cytotoxicity with human serum albumin-monensinA A Hertler, D M Schlossman, M J Borowitz, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancer Treatment and Research|January 1, 1988
Human immune response to immunotoxinsA A Hertler
Cancer Investigation|January 1, 1991
Immunotoxins in the therapy of leukemias and lymphomasA A Hertler, A E Frankel
Clinics in Geriatric Medicine|November 1, 1987
Sarcomas in the elderlyA A Hertler, J O Moore
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Immunotoxins: a clinical review of their use in the treatment of malignanciesA A Hertler, A E Frankel
Journal of Clinical & Laboratory Immunology|December 1, 1986
Effect of intravenous immunoglobulin on E. coli opsonization in multiple myelomaA A Hertler, S C Ross
American Journal of Hematology|December 1, 1986
Isolated anterior chamber relapse in acute monoblastic leukemiaA A Hertler, G O Rosenwasser, W L Gluck
Cancer Drug Delivery|January 1, 1987
Humoral immune response to a ricin A chain immunotoxin in patients with metastatic melanomaA A Hertler, L E Spitler, A E Frankel
Cancer Immunology, Immunotherapy : CII|January 1, 1989
An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeysA A Hertler, D M Schlossman, M J Borowitz, et al.
Cancer Treatment and Research|January 1, 1988
Treatment of leukemia patients with T101 ricin A chain immunotoxinsG Laurent, A E Frankel, A A Hertler, et al.
International Journal of Cancer|February 15, 1989
An anti-CD5 immunotoxin for chronic lymphocytic leukemia: enhancement of cytotoxicity with human serum albumin-monensinA A Hertler, D M Schlossman, M J Borowitz, et al.
Pageof 2